Enhanced Release Kinetics and Stability of Resveratrol Loaded Self Nanoemulsifying Delivery Systems Developed using Experimental Design

Author(s): Monika Sharma*, Rajeev Garg*, Satish Sardana.

Journal Name: Current Nanomedicine
Formerly Recent Patents on Nanomedicine

Volume 9 , Issue 2 , 2019

Become EABM
Become Reviewer

Graphical Abstract:


Abstract:

Background: Resveratrol is a member of the stilbene family emerged as a leading candidate for improving healthspan through potentially slowing the aging process and preventing chronic diseases. A number of institutions and scientists specialized in this field across the world are working to develop a promising Self Emulsifying formulation to enhance bioavailability of hydrophobic resveratrol using oil.

Objectives: The objective of the current study is to develop self-nano emulsifying drug delivery systems using long-chain triglycerides of resveratrol to enhance solubility, stability, release kinetics and to overcome low bioavailability.

Methods: Solubility studies performed in different lipids, surfactants and cosurfactants. Phase diagrams constructed to select the areas of nanoemulsion. SNEDDS formulation was optimized using 33 central composite design considering lipid (X1), surfactant (X2) and co-surfactant (X3) as critical variables, optimized formulation was located using overlay plot.

Results: The nanometer size and high values of zeta potential depicted non-coalescent nature of SNEDDS. The resulted SNEDDS formulation had improved in vitro release followed by Hixson Crowell model with higher regression R2value 0. 929. Thermodynamic stability studies ascertained stable formulation. Mean droplet size in selected nanocarrier was found to be 83.29 nm. The nanocarriers subjected to 2-8°C (45% RH), 25-30°C (60% RH) and 45-50°C (75% RH) in glass vials exhibited no significant changes in 3 months.

Conclusion: The novel approach was developed by selecting optimum blends of lipids, surfactants and cosurfactant using central composite design. This study not only offers a good example of augmenting bioavailability of resveratrol but will also provide a promising oral formulation for clinical application.

Keywords: Self nanoemulsifying drug delivery system (SNEDDS), resveratrol, solubility, stability, surfactants, bioavailability.

[1]
Qian J, Meng H, Xin L, et al. Self-nanoemulsifying drug delivery systems of myricetin: Formulation development, characterization, and in vitro and in vivo evaluation. Colloids Surf B Biointerfaces 2017; 160: 101-9.
[2]
Singh B, Garg B, Kaur R, Jain A, Kumar R, Prakash Om. Self-nanoemulsifying systems for oral bioavailability enhancement. Fabrication and Self-Assembly of Nanobiomaterials 2017; pp. 91-115.
[3]
Basalious EB, Shawky N, Badr-Eldin SM. SNEDDS containing bioenhancers for improvement of dissolution and oral absorption of lacidipine. I: development and optimization. Int J Pharm 2010; 391: 203-11.
[4]
Porter CJ, Charman WN. Intestinal lymphatic drug transport: an update. Adv Drug Deliv Rev 2001; 50: 61-80.
[5]
AboulFotouh K. Allam AA, El-Badry M, El-Sayed AM. Development and in vitro/in vivo performance of self-nanoemulsifying drug delivery systems loaded with candesartan cilexetil. Eur J Pharm Sci 2017; 15(109): 503-13.
[6]
Irina C, Abraham JD, Amnon H. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects. Expert Opin Drug Deliv 2015; 12(7): 1121-33.
[7]
Jeevana JB, Sreelakshmi K. Design and evaluation of selfnanoemulsifying drug delivery system of flutamide. J Young Pharm 2011; 3: 4-8.
[8]
Porter CJ, Trevaskis NL, Charman WN. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat Rev Drug Discov 2007; 6: 231-48.
[9]
Bandyopadhyay S, Katare OP, Singh B. Optimized self-nanoemulsifying systems of ezetimibe with enhanced bioavailability potential using long chain and medium chain triglycerides. Colloids Surf B Biointerfaces 2012; 100: 50-61.
[10]
Nielsen FS, Petersen KB, Müllertz A. Bioavailability of probucol from lipid and surfactant based formulations in minipigs: influence of droplet size and dietary state. Eur J Pharm Biopharm 2008; 69: 553-62.
[11]
Amri A, Chaumeil JC, Sfar S, Charrueau C. Administration of resveratrol: What formulation solutions to bioavailability limitations? J Control Release 2012; 158: 182-93.
[12]
Pangeni R. Jasjeet Sahni, Javed Ali K, Sharma S. Resveratrol: review on therapeutic potential and recent advances in drug delivery. Informa Healthcare 2014; 11(8): 1285-98.
[13]
Donatella P, Maria PF, Fatima A, et al. Resveratrol (trans-3,5,4-trihydroxystilbene; RSV) and its properties in oral disease. Exp Thera. Med 2017; 14(1): 3-9.
[14]
Monika Garg R, Sardana S. Research Problems Associated with Resveratrol (trans-3,5,4-trihydroxystilbene; RSV) and Various Strategies to Overcome those Problems. Curr Drug Deliv 2017; 14(3): 364-76.
[15]
Caymanchem, assessed on 2014. Available from; https://www.caymanchem.com/pdfs/70675.pdf-CAS510-36-0.
[16]
Marier JF, Vachon P, Gritsas A. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002; 302: 369-73.
[17]
Singh G, Pai RS. Pharmacokinetics and in vivo bio distribution of optimized PLGA nanoparticulate drug delivery system for controlled release of emtricitabine. Drug Deliv 2013; 23(9): 3209-23.
[18]
Singh G, Pai RS. Trans-resveratrol self-nanoemulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv 2015; 22(4): 522-30.
[19]
Wegiel LA, Mauer LJ, Edgar KJ, Taylor LS. Crystallization of amorphous solid dispersions of resveratrol during preparation and storage-impact of different polymers. J Pharm Sci 2013; 102: 171-84.
[20]
Troche-Pesqueira E, Perez-Juste I, Navarro-Vazquez A. Cid. MM. A b-cyclodextrin-resveratrol inclusion complex and the role of geometrical and electronic effects on its electronic induced circular dichroism. RSC Advances 2013; 3: 10242-50.
[21]
Gehan F, Naser A, Mohamad AS, et al. Resveratrol β-cyclodextrin/lecithin complexes: A new approach for treatment of hepatic dysfunction. J Pharm Pharm Sci 2017; 6(1): 1-15.
[22]
Bandyopadhyay S, Katare O, Singh B. Development of optimized supersaturable self-nanoemulsifying systems of ezetimibe: effect of polymers and efflux transporters. Expert Opin Drug Deliv 2014; 11: 479-92.
[23]
Azeem A, Rizwan MF, Ahmad J. Nanoemulsion components screening and selection: a technical note. AAPS PharmSciTech 2009; 10(1): 69-76.
[24]
Singh G, Pai RS, Devi VK. Response surface methodology and process optimization of sustained release pellets using Taguchi orthogonal array design and central composite design. J Adv Pharm Technol Res 2012; 3: 30-40. a
[25]
Dash RN, Mohammed H, Humaira T. Design, optimization, and evaluation of ezetimibe solid supersaturatable self-nanoemulsifying drug delivery for enhanced solubility and dissolution. Journal of Pharmaceutical Investigation 2016; 46(2): 153-68.
[26]
Patel G, Shelat P, Lalwani A. Statistical modeling, optimization and characterization of solid self-nanoemulsifying drug delivery system of lopinavir using design of experiment. Drug Deliv 2016; 23(8): 3027-42.
[27]
Khan AW, Kotta S, Ansari SH, Sharma RK, Ali A. Self-nanoemulsifying drug delivery system (SNEDDS) of the poorly water-soluble grapefruit flavonoid Naringenin: design, characterization, in vitro and in vivo evaluation. Drug Deliv 2015; 22(4): 552-61.
[28]
Puri R, Mahajan M, Sahajpal NS, Singh H, Singh H, Jain SK. Self-nanoemulsifying drug delivery system of docosahexanoic acid: development, in vitro- in vivo characterization. Drug Dev Ind Pharm 2016; 42(7): 1032-41.
[29]
Soltani Y, Goodarzi N, Mahjub R. Preparation and characterization of self nano-emulsifying drug delivery system (SNEDDS) for oral delivery of heparin using hydrophobic complexation by cationic polymer of β-cyclodextrin. Drug Dev Ind Pharm 2017; 43(11): 1899-907.
[30]
Barzegar-Jalali M, Adbika K, Valizadeh H, et al. Kinetic analysis of drug release from nanoparticles. J Pharm Sci 2008; 11(1): 167-77.
[31]
Swenson ES, Milisen WB, Curatolo W. Intestinal permeability enhancement: efficacy, acute local toxicity, and reversibility. Pharm Res 1994; 11: 1132-42.
[32]
Gupta S, Chavhan S, Sawant KK. Self-nanoemulsifying drug delivery system for adefovir dipivoxil: design, characterization, in vitro and ex vivo evaluation. Colloids Surf A Physicochem Eng Asp 2011; 392: 145-55.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 9
ISSUE: 2
Year: 2019
Page: [128 - 145]
Pages: 18
DOI: 10.2174/2468187308666180613104123
Price: $58

Article Metrics

PDF: 31
HTML: 4

Special-new-year-discount